Financial Statements for the period from January 2022 to December 2022 CHAE
Document47 pages, text from the fileOpen DFM’s file
Page 1
,j�T��CHlMIRA04/ 04 / 2023Mr. Hamed Ahmed AliCEODubai Financial Market (DFM)Dubai, United Arab EmiratesDear Sir,
Subject: Notification by Chimera Capital Limited on behalf of Chimera UCITS ICAV Please be informed that Chimera Capital Limited received the enclosed Condensed Interim Report & Unaudited Financial Statements from Chimera UCITS ICAV for the period pt January 2022 to 3pt December 2022.
Sincerely,
I' _p.o.)1 � ..1.4.>i J..ol> / �I 4.5�1..,.,./J}I
a:il:,j -4 J�\S" � aS' � IJ'° ;lb>! :e.,,,o j,4-ll J�l�J:!��
�I aj J�t)' � a5 ,P 0� ��I � y
. w..WI . a.J.> • t\ o· .. q a..JWk.Jul...JI --0-" .I::'- - :r- >_r1:' :r' - - . ..):_JJU n Jl,. n Y-1..: 1 i:ro ofiill J�1 �Y-�
.,.n fa.-w-:1�. ----�!Ill .. ..... .�l-UJ_.P Sherif SalemCIO - Public Markets �WI Jl_,...,�1 -JWL..)11 tlhl �J
Attached : Chimera UCITS !CA V Condensed Interim Report & Unaudited Financial Statements
�J\.;,\SI�
;�I ;_,,,..,._JI -'.,\}.,)'I, ._,,.l,yi •<; .;W\; ..>Jje. ,<>,, ,-lJ � ,<> ,-lJ j;U. ,01.i.JI?. ,_,.JWI ._,,.l,J/1 J ,., ;.._,_,;.
Chimera Capital Limited
Office 3502, 35th Floor, Al Maqam Tower, ADGM Square, Al Maryah Island, Abu Dhabi, UAE T: +971 2 885 6666 F: +971 2 885 6660 E: contact@chimerainvestment.com
chimerainvestment.com
Chimera Capital Limited is duly licensed and regulated by the AOGM Financial Services Regulatory Authority.
04/04/2023
Page 2
Chimera UCITS ICAV
Annual Report & Audited Financial Statements
For the financial year ended 31 December 2022
ICAV Registration Number: C188915
Page 3
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
ContentsPage
Directors and Other Information 1
Directors’ Report 2
Report from the Depositary to the Shareholders 6
Investment Manager’s Report 7
Independent Auditor’s Report 9
Statement of Financial Position 16
Statement of Comprehensive Income 17
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares 18
Statement of Cash Flows 19
Notes to the Audited Financial Statements 20
Schedule of Investments 38
Statement of Portfolio Changes (Unaudited) 40
Appendix I: UCITS V Remuneration Policy (Unaudited) 42
Appendix II: Securities Financing Transactions Regulation (“SFTR”) Disclosures (Unaudited) 43
Appendix III: Sustainable Finance Disclosure Regulation (“SFDR”) Disclosures (Unaudited) 44
Page 4
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
1Directors and Other InformationDirectors of the ICAVFeargal Dempsey (Irish)1Seif Fikry (Egyptian) 2
Majed Odeh (Jordanian) 2 (Resigned 17 November 2022) Jason Loveless (British) 2
Syl O’Byrne (Irish) 1Sherif Salem (Egyptian) 2 (Appointed 17 November 2022)
Manager
FundRock Management Company S.A.
33, rue de GasperichL-5826 HesperangeGrand-Duchy of Luxembourg
Registered Office of the ICAVEffective 14 November 2022County HallDooradoyle Road, LimerickV94 WV78Ireland
Up to 13 November 2022Suite 5, Block 1International Science CentreNational Technology ParkCastletroy, LimerickIreland
Investment Manager and Global Distributor Chimera Capital Limited
3502, 35th Floor, Al Maqam Tower ADGM Square
Al Maryah IslandAbu DhabiUnited Arab Emirates
Depositary
The Bank of New York Mellon SA/NV, Dublin Branch Riverside II
Sir John Rogerson’s QuayGrand Canal DockDublin 2Ireland
Administrator, Registrar and Transfer AgentBNY Mellon Fund Services (Ireland)Designated Activity CompanyOne Dockland CentralGuild Street
International Financial Services Centre Dublin 1
Ireland
SecretaryEffective 10 March 2023Bradwell Limited10 Earlsfort TerraceDublin 2D02 T380Ireland
Up to 10 March 2023
FundRock Management Company S.A. (Ireland Branch) County Hall
Dooradoyle Road, LimerickV94 WV78Ireland
Independent AuditorsDeloitte Ireland LLP29 Earlsfort TerraceDublin 2Ireland
Irish Legal AdvisersArthur CoxTen Earlsfort TerraceDublin 2Ireland
1 Independent and Non-executive Director.
2 Non-executive Director.
Page 5
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
2Directors’ Report
The Board of Directors (the “Directors”) present th eir Annual Report together with the audited financial statements of the Chimera UCITS ICAV (the “ICAV”) for the financial year ende d 31 December 2022 (the “financial year”).
Statement of Directors' Responsibilities
The Directors are responsible for preparing the Dir ectors’ Report and financial statements of Chimera UCITS ICAV, in accordance with applicable law and regulations.
The Irish Collective Asset-Management Vehicles Act 2015 and 2020 (the “ICAV Act”) Section 116 requires the Directors to prepare financial statements for each financial yea r. Under that law they have elected to prepare the financial statements in accordance with International Financial Reporting S tandards (“IFRS”) as adopted by the European Union (“EU”) and applicable law.
Under the ICAV Act the Directors must not approve t he financial statements unless they are satisfied t hat they give a true and fair view of the assets, liabilities and financial posit ion of the ICAV and of its changes in net assets at tributable to holders of redeemable participating shares for that financial year. In preparing the financial statements, the Directors are required to:
• select suitable accounting policies and then apply them consistently;
• make judgements and estimates that are reasonable and prudent;
• state whether the financial statements have been pr epared in accordance with IFRS and ensure that they contain the additional information required by the ICAV Act;
• assess the ICAV's ability to continue as a going concern, disclosing, as applicable, matters related to going concern; and
• prepare the financial statements on the going conce rn basis unless it is inappropriate to presume that the ICAV will continue in business.
The Directors confirm that they have complied with the above requirements in preparing the financial statements.
The Directors are also responsible for safeguarding the assets of the ICAV and hence for taking reason able steps for the prevention and detection of fraud and other irregularities.
Under the European Communities (Undertakings for Co llective Investment in Transferable Securities) Reg ulations, 2011, as amended (the “UCITS Regulations”), the Central Bank (Supervision and Enforcement Act 2013 (Section 48( 1)) (Undertakings for Collective Investment in Transferable Securities) R egulations 2019 (the “Central Bank UCITS Regulation s”), the Directors are required to entrust the assets of the ICAV to a dep ositary for safekeeping. In carrying out this duty, the Directors have delegated custody of the ICAV’s assets to The Bank of New Yor k Mellon SA/NV, Dublin Branch (the “Depositary”). T hey have general responsibility for taking such steps as are reasona bly open to them to prevent and detect fraud and ot her irregularities. The Directors are also responsible for preparing a Directors’ Report that complies with the requirements o f the ICAV Act.
Adequate Accounting Records
The ICAV has appointed FundRock Management Company S.A. as its Manager (the “Manager”) pursuant to the Management Agreement. Under the terms of the Management Agreem ent, the Manager has responsibility for the managem ent and administration of the ICAV’s affairs and the distri bution of the shares, subject to the overall superv ision and control of the Directors.
The Manager has delegated the administration and tr ansfer agency functions to an administrator and has therefore appointed BNY Mellon Fund Services (Ireland) Designated Activity Company to act as administrator (the “Administrator ”), registrar and transfer agent of the ICAV with responsibility for performing the day to day administration of the ICAV.
The Directors believe that they have complied with the requirements of Sections 109 to 113 of the ICAV Act, with regard to keeping adequate accounting records in respect of t he ICAV by appointing the Administrator which has a ppropriate expertise, adequate resources and appropriate systems and proc edures. The accounting records of the ICAV are kept by the Administrator at their registered office at: One Dockland Central, G uild Street, International Financial Services Centr e, Dublin 1, D01 E4XO, Ireland.
Page 6
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
3Directors’ Report (continued)
Corporate Governance StatementThe ICAV is subject to corporate governance practices imposed by:
(i) The ICAV Act, which is available for inspection at the registered office of the ICAV, and may also be obtained at http://www.irishstatutebook.ie ;
(ii) The Instrument of Incorporation of the ICAV which i s available for inspection at the registered office of the ICAV at 3-4
Upper Pembroke Street, Dublin 2, Ireland;
(iii) The Central Bank of Ireland (“CBI”) in their UCITS Regulations which can be obtained from the CBI webs ite at www.centralbank.ie and are available for inspection at the registered office of the ICAV; and
From the inception of the ICAV, the Directors volun tarily adopted and applied the Irish Funds’ Corpora te Governance Code (the “IF Code”) for Irish domiciled collective investmen t schemes and management companies as published by the Irish Funds, the full text of which is available from the Irish Fund s’ website at www.irishfunds.ie. The ICAV has been fully compliant with the corporate governance practices during the financial year.
The ICAV is not subject to the amendments to general corporate law required by any European directives.
Composition and Operation of the Board of Directors
Unless otherwise determined by an ordinary resoluti on of the ICAV in general meeting and in accordance with Section 56 of the ICAV Act, the number of Directors may not be less t han two or more than twelve. Currently the Board of Directors of the ICAV is composed of five Directors.
The business of the ICAV is managed by the Director s, who exercise all such powers of the ICAV which a re not required by the ICAV Act or by the Instrument of Incorporation of t he ICAV to be exercised by the ICAV in a general me eting. The Directors meet on a quarterly basis or more frequently, if required.
A Director may, and the Secretary of the ICAV on th e requisition of a Director will, at any time summo n a meeting of the Directors. Questions arising at any meeting of the Directors are determined by a majority of votes. In the case of an equality of votes, the Chairman has a second or casting vote. T he quorum necessary for the transaction of business at a meeting of the Directors is two.
Directors and Secretary
The Directors that served at any time during the fi nancial year are listed in the Directors and Other Information on page 1.
FundRock Management Company S.A. held the office of ICAV Secretary (the “Secretary”) throughout the fi nancial year.
Directors’ Remuneration
The Board of Directors as a whole reviews Directors ’ remuneration. The Director’s policy is that the r emuneration of independent non-executive Directors should be fair and reasonab le in relation to the time commitment and responsib ilities of the Directors. The fees of the independent non-executive Directors are paid by the ICAV. The other Directors are not entitled to any fees.
Directors’ and Secretary’s Interests in Shares and Contracts
The Directors, Secretary and their families had no interest in the shares of the ICAV at 31 December 2 022. Other than as disclosed in Note 10 to the Financial Statements, none of the Directors had a material interest in any contract or agreement of significance, as defined in the ICAV Act, during or at the end of the financial year in relation to the business of the ICAV.
Employees
The governance framework of the ICAV reflects the f act that it has no employees or subsidiary companie s and outsources investment management, distribution and administration.
Page 7
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
4Directors’ Report (continued)
Transactions with Connected Persons
Regulation 43 of the Central Bank UCITS Regulations “Restrictions of transactions with connected perso ns” states that “A responsible person shall ensure that any transactio n between a UCITS and a connected person is conduct ed a) at arm’s length; and b) in the best interest of the shareholders of the UCITS”.
As required under the Central Bank UCITS Regulation 81 (4), the Manager, as responsible person, has co nfirmed to the Board of Directors of the ICAV that it is satisfied that the re are arrangements in place, evidenced by written procedures, to ensure that obligations set out in Regulation 43(1) are applied to all transactions with connected persons; and al l transactions with connected persons that were entered into during the financial year to which the report relates, complied with th e obligations that are prescribed by Regulation 43(1).
Principal Activities, Review of the Business and Future Developments
The ICAV is an open-ended Irish collective asset-ma nagement vehicle with segregated liability between Sub-Fund established under the laws of Ireland pursuant to the ICAV Act, the UCITS Regulations and the Central Bank UCITS R egulations. It was incorporated on 21 January 2019.
Each Sub-Fund may comprise one or more classes of s hares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, establish further Sub-Funds by the issue of one or more separate classes of share s on such terms as the Directors may resolve. The Directors may, from time to time, in accordance with the requirements of th e CBI, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.
As at 31 December 2022, the ICAV consisted of only one Sub-Fund - Chimera S&P UAE UCITS ETF (the “Sub- Fund”). The Sub-Fund was launched on 23 February 2021.
The Sub-Fund seeks to provide investors with a tota l return, taking into account capital and income re turns, which reflects the return of an equity index called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”).
The Investment Manager's Report from pages 7 to 8 c ontains a review of the factors which contributed t o the performance for the financial year ended 31 December 2022.
Principal Risks and Uncertainties
The main risks arising from the ICAV's financial in struments are Investment strategy, Pricing and Valu ation Risk, Counterparty
Credit & Settlement Risk, Foreign Currency Risk, Cr edit Risk with respect to Cash, Interest Rate Risk, Liquidity Risk, Global
Exposure and Fair Value which are outlined in Note 3 to these financial statements. Risk information is outlined in the Prospectus.
The maintenance and integrity of the financial statements published on the Chimera website are the Directors' responsibility.
Going Concern
The ICAV and Sub-Fund will continue in business and the financial statements have been prepared on a going concern basis.
Relevant Audit Information
So far as the Directors are aware, there is no rele vant audit information of which the ICAV’s auditors are unaware and the Directors have taken all the steps that should have been taken as Directors in order to make themselve s aware of any relevant audit information and to establish that the ICAV’s auditors are aware of that information.
Page 8
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
5Directors’ Report (continued)Results and Dividends
The results for the financial year are set out in t he Statement of Comprehensive Income. The Directors are empowered by the Instrument of Incorporation to declare and pay divi dends, in respect of Shares in any Distributing Sha re Class out of net income (including dividend and interest income) and/or capital. Dividends paid out of capital are designed to a return or withdrawal of part of a Shareholder’s original investment or from any capital gains attributable to that original investm ent. It is not the current intention of the Directors to declare dividends in respect of the Sub-Fund.
Independent Auditors
Deloitte Ireland LLP, Chartered Accountants and Sta tutory Audit Firm, have indicated their willingness to continue as auditors in accordance with the ICAV Act 2015.
On behalf of the Board of Directors:
Director:______________________ Director:______________________Feargal Dempsey Syl O'Byrne
Date: 23 March 2023
Page 9
The Bank of New York Mellon SA/NV, T +353 1 900 7920 Dublin Branch F +353 1 829 1024
Riverside II, Sir John Rogerson’s Quay,Grand Canal Dock, Dublin 2, D02 KV60
Registered in Ireland No. 907126, VAT No. IE9578054E
The Bank of New York Mellon SA/NV, trading as The Bank of New York Mellon SA/NV, Dublin Branch is authorised by the National Bank of Belgium regulated by the Central Bank of Ireland for conduct of business rules.
The Bank of New York Mellon SA/NV, 46 Rue Montoyerstraat, B-1000 Brussels, Belgium - Tel. (32) 2 545 81 11, V.A.T. BE 0806.743.159 - RPM-RPR Brussels Company No. 0806.743.159. The Bank of New York Mellon SA/NV is a Belgian limited liability company, authorized and regulated as a si gnificant credit institution by the European Central Bank and the National Bank of Belgium under the Single Supervisory Mechanism and by the Belgian Financial Services and Markets Authority.
Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2022
Report from the Depositary to the Shareholders
For the financial period from 1 January 2022 to 31 December 2022 (the “ Period”). The Bank of New York Mellon SA/NV, Dublin Branch (the “Depositary” “us”, “we”, or “our”), has enquired into the conduct of Chimera UCITS ICAV (the “ICAV”) for the Period, in its capacity as depositary to the ICAV. This report including the opinion has been prepared for and so lely for the Shareholders in the ICAV, in accordance with our role as depositary to the ICAV and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown.
Responsibilities of the Depositary
Our duties and responsibilities are outlined in Regulation 34 of the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011 (S.I. No 352 of 2011), as amended (the “R egulations”).
Our report shall state whether, in our opinion, the ICAV has been managed in that period in accordance with the provisions of the ICAV’s constitutional documents and the Regulations. It is the overall responsibility of the ICAV to comply with these provisions. If the ICAV has not been so managed, we as depositary must state in what respects it has not been so managed and the steps which we have taken in respect thereof.
Basis of Depositary Opinion
The Depositary conducts such reviews as it, in its reasonable opinion, considers necessary in order to comply with its duties and to ensure that, in all material respects, the ICAV has been managed (i) in accordance with the limitations imposed on its investment and borrowing powers by the provisions of its constitutional documentation and the appropriate regulations and (ii) otherwise in accordance with the ICAV’s constitutional documentation and the appropriate regulations.
Opinion
In our opinion, the ICAV has been managed during the Period, in all material respects:
(i) in accordance with the limitations imposed on the investment and borrowing powers of the ICAV by the constitutional documentation and by the Regulations; and
(ii) otherwise in accordance with the provisions of the constitutional documentation and the R egulations.
For and on behalf of The Bank of New York Mellon SA/NV, Dublin BranchRiverside II,Sir John Rogerson’s Quay,Grand Canal Dock,Dublin 2
Date: 23 March 2023Michelle Moroney
Page 10
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
7Investment Manager’s Report
The Chimera S&P UAE UCITS ETF (the “Sub-Fund”) is a Sub-Fund of the Chimera UCITS ICAV. It was launche d in February 2021, and as of December 2022 has assets under management of AED 131.4 million.
Sub-Fund Performance
The Sub-Fund's Abu Dhabi Securities Exchange (“ADX” ) listed Share Class D (CHAEIN) ended the year with a NAV of AED 4.451 and the Dubai Financial Market (“DFM”) listed Share Class A (CHAE) had an NAV of AED 4.719.
The total return for the Sub-Fund in 2022 was -4.8% , while the S&P UAE BMI Liquid 20/35 Capped Index’s (Bloomberg code:
SPUAECAN) was -3.9% during the year.
During the fourth quarter of 2022, a dividend of AE D 0.0739 was announced for the ADX-listed Share Cla ss D, implying that total dividends distributed during 2022 for the ETF will be AED 0.1325, and translating into a dividen d yield of 2.92% based on the end of December NAV. The ex-dividend date was 15 December 2022 and payment date is 11 January 2023.
*The Sub-Fund and Index data specified in the graph are calculated since inception of the Sub-Fund
** Data Source: Based on figures provided by the Administrator – BNY Mellon Fund Services (Ireland) DA C
Tracking Difference
The tracking error for the Sub-Fund in 2022 was 0.32%, and the net tracking difference was -0.19%.
2021 2022 ITD*
ETF Return35.1%-4.8%28.6%
Index Return36.4%-3.9%31.1%
Tracking Diff (bps)-133.1-90.4-249.9
Total Expense Ratio (bps)88.671.4183.1
Tracking Diff Net (bps)-44.5-18.9-66.8
Tracking Error (bps)36.931.732.7
*Since inception date 23 February 2021
As stated under the investment policy of the Sub-Fund's Prospectus, a maximum level of tracking difference and tracking error of up to 2% each, (net of fees) per annum will be maintained.
Page 11
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
8Investment Manager’s Report (continued)
Assets Under Management (“AUM”)
The AUM of the Sub-Fund stood at AED 131.4 million on 30 December 2022, of which the AUM of Share Clas s D – Distributing (CHAEIN), listed on the Abu Dhabi Secu rities Exchange (ADX) were AED 129.1 million and Sh are Class A – Accumulating (CHAE), listed on the Dubai Financial Market (DFM) were AED 2.3 million.
During the year, the CHAEIN share class traded a to tal of AED 78 million in the secondary market, or a n average of AED 6.5 million per month, compared to 2021’s average of AE D 10.6 million. Moreover, in April there was AED 21 million traded on the secondary market, making it the second highest value traded since listing. During 2022, the CHAE s hare class traded a total of 0.9 million in the secondary market.
The primary market activity has also been resilient , with a total traded value of AED 89.5 million (14 million units redeemed and 3.5 million units created). Total trading, in b oth the primary and secondary markets, across both share classes reached AED 168.4 million in 2022.
The S&P UAE BMI 35/20 Liquid Capped Index methodolo gy had been amended during the fourth quarter by S& P Dow Jones to limit the number of constituents to 30. That ame ndment was effective during the latest quarterly re balance that took place on 16 December 2022 resulting in an increase in the number of constituents to 30 by end of 2022, up from 25 at the end of 2021.
Market Commentary
The ADX General Index’s 20.3% return in 2022 was ra nked as the eighth best performing index globally a ccording to Bloomberg data while the DFM returned 4.4% during the year.
During the year, Emaar Properties was the best perf ormer among the real estate names, closing the year 19.8% higher while subsidiary Emaar Development rose 0.9%. Both firms were beneficiaries of a strong recovery in UAE’s pr operty market boosted by global events including Expo 2020 and the World Cup in Qatar. In Abu Dhabi, Aldar Properties rose 11.0% over the year after a string of value accretive additions to the company’s recurring income portfolio. The bank ing sector meanwhile endured a mixed bag. Index heavyweight FAB declined 8.2% while Emirates NBD declined 4.1%. Retail-tilt ed banks outperformed, with ADIB surging 32.6% alongside ADC B which added 5.5%. Finally, blue-chip telecom oper ator Etisalat had a volatile year declining 27.9% over the whole of 2 022 and 41.4% from an all-time high the stock reach ed in April. Following the announcement that the company was increasing it s foreign ownership limit, the stock hit an all-tim e high of AED39.06, but then gave up the gains following the easing of the buying pressure from index tracking ETFs.
During the year, there were six listings on the ADX and five listings on the DFM boosting the combined market capitalisation of the two markets to AED 3.2 trillion ($857.4 billion), o f which the ADX is AED 2.6 trillion ($713.0 billion ) and the DFM is AED 530 billion ($144.4 billion). The IPOs, which saw total demand reach $377.4 bill ion, have helped UAE and the region become a bright spot in an otherwise bleak global I PO market. DEWA’s IPO came out on top with total pr oceeds of $6 billion, while Borouge’s offering achieved total proceeds of more than $2 billion. Finally, Americana raised $1 .7 billion in gross proceeds in its historic deal listing IPO on the ADX and Saudi Arabia’s Tadawul.
Chimera Capital LimitedDate: January 2023
Page 12
Deloitte Ireland LLPChartered Accountants &Statutory Audit Firm
Independent auditor’s report to the members of Chimera UCITS ICAV Report on the audit of the financial statements
Opinion on the financial statements of Chimera UCITS ICAV (‘ICAV’)In our opinion the financial statements:
give a true and fair view of the assets, liabilities and financial position of the ICAV as at 31 December 2022 and of the loss for the year then ended; and
have been properly prepared in accordance with the relevant financial reporting framework and the Applicable Regulations.
The financial statements we have audited comprise:the Statement of Financial Position;the Statement of Comprehensive Income;
the Statement of Changes in Net Assets Attributable to holders Redeemable Participating Shares;
the Statement of Cash Flows; and
the related notes 1 to 23, including a summary of significant accounting policies as set out in note 2.
The relevant financial reporting framework that has been applied in the preparation of the financial statements is the Irish Collective Asset-Management Vehicles Acts 2015-2020 (“the ICAV Act”) and International Financial Reporting Standards (IFRS) as adopted by the European Union (“the relevant financial reporting framework”).
The applicable regulations that have been applied in their preparation is the European Communities (Undertakings for Collective Investment in Transferable Securities) Regulations 2011, (as amended) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securities) Regulations 2019 (the “Applicable Regulations”).
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (Ireland) (ISAs (Ireland)) and applicable law. Our responsibilities under those standards are described below in the “Auditor's responsibilities for the audit of the financial statements” section of our report.
We are independent of the ICAV in accordance with the ethical requirements that are relevant to our audit of the financial statements in Ireland, including the Ethical Standard issued by the Irish Auditing and Accounting Supervisory Authority, as applied to listed entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Summary of our audit approach
Key audit matters The key audit matters that we identified in the current year were:
Valuation of Level 1 InvestmentsExistence of Level 1 Investments
Within this report, any new key audit matters are identified with and any key audit matters which are the same as the prior year identified with .
Materiality The materiality that we used in the current year was 1% of the Average Net Assets.
Page 13
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAV/Continued on next page
Scoping Our audit is a risk-based approach taking into account the structure of the ICAV, types of investments, the involvement of the third parties service providers, the accounting processes and controls in place and the industry in which the ICAV operates.
Significant changes in ourapproachNo significant changes in our approach.Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Our evaluation of the directors’ assessment of the ICAV ability to continue to adopt the going concern basis of accounting included:
As part of our risk assessment procedures, we obtained an understanding of the relevant controls in place regarding going concern.
Challenged the reasonableness of the key assumptions applied by the directors in their assessment.
Held discussions with management on the directors’ going concern assessment, the future plans for the ICAV and the feasibility of those plans.
Reviewed all board meeting minutes during the financial year up to the date of approval of the financial statements, for evidence of any discussions and/or decisions that could impact the ICAV ability to continue as a going concern.
Reviewed the capital activity and NAV movements, subsequent to the financial year end.
Assessed the adequacy of the relevant going concern disclosures made in the financial statements
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the ICAV ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Key Audit Matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current financial year and include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on: the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team.
These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
Page 14
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAV/Continued on next pageValuation of Level 1 InvestmentsKey audit matterdescription
For the financial year ended the investments of the ICAV of AED 130,827,727 make up 99% of total net assets of AED 131,433,922. The valuation of Level 1 investments is considered a key audit matter as the investments represent a significant balance on the Statement of Financial Position. This is also the main driver of the ICAV performance and has been identified as the most significant risk of material misstatement.
There is a risk that investments traded on an exchange or a secondary market may not be valued correctly in accordance with IFRS 13.
How the scope of ouraudit responded to thekey audit matter
We independently valued all exchange-traded securities using our own market feeds.
We considered the valuation basis used in light of the valuation policy as stipulated in the ICAV prospectus documents and the requirements of IFRS.
We tested the cost of the investment portfolio by performing a book cost reconciliation and ensuring that the correct cost had been recorded.
We reviewed the SOC 1 Report of the BNY and assessed the scope, sufficiency and results of the controls reports with regard to controls over the valuation of investments.
We reviewed the risk disclosure notes in the context of the ICAV to ensure that
the disclosures appropriately reflected the risks of the ICAV.
Our audit procedures relating to these matters were designed in the context of our audit of the financial statements as a whole, and not to express an opinion on individual accounts or disclosures. Our opinion on the financial statements is Existence of Level 1 Investments
Key audit matterdescription
The investment portfolio at the year-end principally comprised equity investments valued at AED 130,827,727. The existence of investments is considered a key audit matter as the investments represent a significant balance on the Statement of Financial Position. This is also the main driver of the ICAV performance and therefore the existence of the investments is a key audit matter.
The existence and recognition of the ICAV investments is crucial to ensuring the financial statements are free from material misstatement. There is a risk that the investments may not exist at financial year end.
How the scope of ouraudit responded to thekey audit matter
We obtained independent confirmation from the depositary as to the existence of the investment portfolio;
Any reconciling items between the depositary confirmation and the ICAV’s investment portfolios (such as late trades or pending settlements) were investigated to ensure that trades were recorded in the correct reporting period;
We tested the cut-off of trades to ensure that they have been recorded in the correct period; and
We reviewed and assessed the scope, sufficiency and results of the SOC1 and whether we could place reliance on this report with regard to controls over the existence of investments.
We reviewed the risk disclosure notes in the context of the ICAV to ensure that the disclosures appropriately reflected the risks of the ICAV.
Page 15
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAV/Continued on next page
not modified with respect to any of the risks described above, and we do not express an opinion on these individual matters.
Our application of materiality
We define materiality as the magnitude of misstatement in the financial statements that makes it probable that the economic decisions of a reasonably knowledgeable person would be changed or influenced. We use materiality both in planning the scope of our audit work and in evaluating the results of our work.
Based on our professional judgement, we determined materiality for the financial statements as a whole as follows:
Materiality AED 1,701,893Basis fordeterminingmateriality1% of Average Net AssetsRationale for thebenchmarkapplied
We have considered the Average Net Assets to be the critical component for determining materiality because the main objective of the ICAV is to provide investors with a total return.
We have considered quantitative and qualitative factors such as understanding the entity and
its environment, reliability of control environment and complexity of the ICAV.
We set performance materiality at a level lower than materiality to reduce the probability that, in aggregate, uncorrected and undetected misstatements exceed the materiality for the financial statements as a whole. Performance materiality was set at 50% of materiality for the 2022 audit. In determining performance materiality, we considered the following factors:
a) Our understanding of the ICAV.
b) The quality of the control environment and whether we are able to rely on controls
c) The nature and extent of misstatements identified in previous audits.
d) Expectations in relation to misstatements in the current period
We agreed with the Board of Directors that we would report to the Board all audit differences in excess of 5% of materiality, as well as differences below that threshold that, in our view, warranted reporting on qualitative grounds.
We also report to the Board of Directors on disclosure matters that we identified when assessing the overall presentation of the financial statements.
An overview of the scope of our audit
Our audit is a risk-based approach taking into account the structure of the ICAV, types of investments, the involvement of the third party service providers, the accounting processes and controls in place and the industry in which the ICAV operates. The ICAV is incorporated as an Irish collective asset management vehicle with variable capital and authorised by the Central Bank of Ireland (the “CBI”) as an Undertaking for Collective Investment in Transferable Securities (“UCITS”) under the Applicable Regulations. We have conducted our audit based on the books and records maintained by the administrator BNY Mellon Fund Services at One Dockland Central, Guild Street, IFSC, Dublin 1, Ireland.
Other information
The other information comprises the information included in the Annual Report and Audited Financial Statements other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the Annual Report and Audited Financial Statements.
Page 16
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAV/Continued on next page
Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.
Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.Responsibilities of directors
As explained more fully in the Directors’ Responsibilities Statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view and otherwise comply with the ICAV Act, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the ICAV’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the ICAV or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion.
Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (Ireland) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
A further description of our responsibilities for the audit of the financial statements is located on IAASA’s website at: https://iaasa.ie/publications/description-of-the-auditors-responsibilities-for-the-audit-of-the-financial-statements/.
This description forms part of our auditor’s report.
Extent to which the audit was considered capable of detecting irregularities, including fraud
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below.
Identifying and assessing potential risks related to irregularities
In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, we considered the following:
the nature of the industry and sector, control environment and business performance;
results of our enquiries of management about their own identification and assessment of the risks of irregularities;
Page 17
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAV/Continued on next page
any matters we identified having obtained and reviewed the ICAV’s documentation of their policies and procedures relating to:
oidentifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance;
odetecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud;
othe internal controls established to mitigate risks of fraud or non-compliance with laws and regulations;
the matters discussed among the audit engagement team and relevant internal specialists regarding how and where fraud might occur in the financial statements and any potential indicators of fraud.
As a result of these procedures, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the following areas: Valuation of Investments and Accuracy of unrealised gain and losses. In common with all audits under ISAs (Ireland), we are also required to perform specific procedures to respond to the risk of management override.
We also obtained an understanding of the legal and regulatory framework that the ICAV operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included the ICAV Act and the Applicable Regulations.
In addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the ICAV’s ability to operate or to avoid a material penalty. These included matters regulated by the Central Bank of Ireland.
Audit response to risks identified
As a result of performing the above, we identified ‘Valuation of Investments’ as a key audit matter related to the potential risk of fraud. The key audit matters section of our report explains the matter in more detail and also describes the specific procedures we performed in response to that key audit matter.
In addition to the above, our procedures to respond to risks identified included the following:
reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with provisions of relevant laws and regulations described as having a direct effect on the financial statements;
enquiring of management and the Board of Directors concerning actual and potential litigation and claims;
performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;
reading minutes of meetings of those charged with governance and reviewing correspondence with the Central Bank of Ireland.
in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments; assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.
We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.
Page 18
/Continued from previous pageINDEPENDENT AUDITOR’S REPORT TO THE MEMBERS OFCHIMERA UCITS ICAVReport on other legal and regulatory requirementsOpinion on other matters prescribed by the ICAV Act
Based solely on the work undertaken in the course of the audit, we report that:
We have obtained all the information and explanations which we consider necessary for the purposes of our audit.
In our opinion the accounting records of the ICAV were sufficient to permit the financial statements to be readily and properly audited.
The financial statements are in agreement with the accounting records.
In our opinion the information given in the directors’ report is consistent with the financial statements and the directors’ report has been prepared in accordance with the ICAV Act.
Matters on which we are required to report by exception
Based on the knowledge and understanding of the ICAV and its environment obtained in the course of the audit, we have not identified material misstatements in the directors' report.
We have nothing to report in respect of the provisions in the ICAV Act which require us to report to you if, in our opinion, the disclosures of directors’ remuneration and transactions specified by law are not made.
Use of our report
This report is made solely to the ICAV’s members, as a body, in accordance with Section 120(1) (b) of the ICAV Act. Our audit work has been undertaken so that we might state to the ICAV’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the ICAV and the ICAV’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Brian JacksonFor and on behalf of Deloitte Ireland LLP
Chartered Accountants and Statutory Audit Firm Deloitte & Touche House, 29 Earlsfort Terrace, Dublin 2 31 March 2023
Page 19
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
16Statement of Financial Position
Chimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETF*
As at31 December2022As at31 December2021
NotesAEDAED
Assets
Cash and cash equivalents 2(m),63,091,743469,871
Financial assets at fair value through profit or loss:
Transferable securities 2(b), 3(i)130,827,727192,305,007
Dividends receivable–79,301
Total assets133,919,470192,854,179
Liabilities
Accrued Management fees(342,448)(329,566)
Distributions Payable(2,143,100)–
Total liabilities(2,485,548)(329,566)
Net assets attributable to holders of redeemable
participating shares14131,433,922
192,524,613
Number of redeemable participating shares
Class A Accumulating Shares4500,000500,000
Class D Distributing Shares429,000,00039,500,000
Net asset value per share attributable to holders of redeemable participating shares
Class A Accumulating Shares144.7194.958
Class D Distributing Shares144.4514.811
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
On behalf of the Board of Directors:
Director:______________________ Director:______________________Feargal Dempsey Syl O'Byrne
Date: 23 March 2023
The accompanying notes form an integral part of the audited financial statements.
Page 20
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
17Statement of Comprehensive Income
Chimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETF*
Financial yearended31 December 2022Financial period from1 July 2020 to31 December 2021
NotesAEDAED
Income
Dividend income 2(e)6,509,5841,334,255
Net (losses)/gains on financial assets at fair value through
profit or loss 2(i),5(6,530,835)20,745,654
Total investment (expense)/income(21,251)22,079,909
Operating expenses
Management fees8(1,709,240)(676,793)
Total operating expenses(1,709,240)(676,793)
Net (expense)/income(1,730,491)21,403,116
Finance costs
Distributions to holders of redeemable participating shares16(4,252,700)(2,724,000)
Interest expense 2(f)–(3)
Total Finance costs(4,252,700)(2,724,003)
(Loss)/profit for the year/period before tax(5,983,191)18,679,113
(Decrease)/increase in net assets resulting fromoperations attributable to holders of redeemableparticipating shares
(5,983,191)18,679,113
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
Gains and losses arose solely from continuing inves tment activities. There were no gains or losses oth er than those dealt with in the Statement of Comprehensive Income.
The accompanying notes form an integral part of the audited financial statements.
Page 21
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
18
Statement of Changes in Net Assets Attributable to Holders of Redeemable Participating Shares
Chimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETF*
Financial yearended31 December 2022Financial period from1 July 2020 to31 December 2021
AEDAED
Net assets attributable to holders of redeemable
participating shares at beginning of the year/period 192,524,613 –
(Decrease)/increase in net assets resulting from operations
attributable to holders of redeemable participating shares(5,983,191)18,679,113
Issue of redeemable participating shares17,193,500173,845,500
Redemption of redeemable participating shares(72,301,000)–
(Decrease)/increase in net assets resulting from share
transactions(55,107,500)173,845,500
Net assets attributable to holders of redeemable
participating shares at end of the year/period 131,433,922 192,524,613
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
The accompanying notes form an integral part of the audited financial statements.
Page 22
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
19
Statement of Cash Flows
Chimera S&P UAEUCITS ETFChimera S&P UAEUCITS ETF*
Financial yearended31 December 2022Financial period from1 July 2020 to31 December 2021
NotesAEDAED
Cash flows from operating activities
Proceeds from sale of investments**69,814,08716,251,939
Purchase of investments**(69,975,142)(13,965,792)
Dividend income received6,588,8851,254,954
Operating expenses paid(1,696,358)(347,227)
Net cash inflow from operating activities4,731,4723,193,874
Cash flows from financing activitiesDistributions paid to holders of redeemable participating
shares16(2,109,600)(2,724,000)
Interest expense paid–(3)
Amounts received on issue of redeemable participating
shares**––
Amounts paid on redemption of redeemable participating
shares**––
Net cash outflow from financing activities(2,109,600)(2,724,003)
Net increase in cash and cash equivalents2,621,872469,871
Cash and cash equivalents at beginning of year/period469,871–
Cash and cash equivalents at end of the year/period 2(m),63,091,743469,871
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
** The Sub-Fund engaged in in-kind subscriptions an d redemptions of redeemable participating shares du ring the financial year amounting to AED 17,193,500 (31 December 2021: AED 173,845,500) and AED 72,301,000 (31 December 2021: AED Nil), respectively (refer to Notes 2(g) and 4 to the fina ncial statements for further details). All the subs criptions into and redemptions out of the Sub-Fund for the financial year/period, were achieved via in-kind contribution and withdraw al of assets of the same amount representing consideration for purchase and sale of investments.
The accompanying notes form an integral part of the audited financial statements.
Page 23
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements20
1. Organisation
Chimera UCITS ICAV (the ‘’ICAV’’) is an Irish colle ctive asset-management vehicle registered in Irelan d pursuant to the Irish Collective Asset-Management Vehicles Act 2015 (the “ICAV Act”) on 21 January 2019 with registration nu mber C188915 and was authorised by the Central Bank of Ireland (the “CBI”) on 18 November 2020 as an Undertaking for Co llective Investment in Transferable Securities (“UCITS”) under the provisi ons of the European Communities (Undertakings for C ollective Investment in Transferable Securities) Regulations 2011, (as amen ded) (the “UCITS Regulations”) and the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) (Undertakings for Collective Investment in Transferable Securiti es) Regulations 2019 (the “Central Bank UCITS Regulations”).
The ICAV is structured as an umbrella fund with seg regated liability between Funds (individually a “Su b-Fund” and collectively “Sub-Funds”). The Instrument of Incorporation provi des that the ICAV may offer separate classes of sha res, each representing interests in a Sub-Fund comprising a distinct portf olio of investments. In addition, each Sub-Fund may be further divided into a number of different classes within the Sub-Fund. Wi th the prior approval of the CBI, the ICAV from tim e to time may create additional Sub-Funds. The creation of further share classes shall be notified to and prepared and subm itted to the CBI in accordance with the CBI requirements.
As at 31 December 2022, the ICAV consisted of one S ub-Fund, Chimera S&P UAE UCITS ETF which was launch ed on 23
February 2021.
The Sub-Fund seeks to provide investors with a tota l return, taking into account capital and income re turns, which reflects the return of an equity index called the S&P UAE BMI Liquid 20/35 Capped Index (the “Index”).
The Index is a modified weighted total return index measuring the performance of 30 of the largest con stituents of the S&P UAE BMI Index. The S&P UAE BMI Index is a leading bench mark for tracking performance of the UAE equity mar kets. The Index is comprised of the constituents of the S&P UAE BMI In dex that meet the following eligibility requirement s: (i) companies must have no more than ten non-trading days over the pre vious quarter; and (ii) have a three-month average daily value traded volume of at least US$ 500,000 for at least one of the two quarterly periods preceding the rebalancing reference date.
The Index applies a UCITS capping screen of 20/35. This is to allow the Fund, whose policy is to repli cate the Index, to invest up to 20% of its net assets in individual securities w ith the 20% limit being raised up to 35% in the cas e of a single issuer where justified by exceptional market conditions which ma y include the dominance of a particular issuer in t he relevant market. The Index provider, S&P, has set triggers in place of at 33%/19% respectively to reset levels to ensure UCITS compliance at all times.
In order to achieve its investment objective, the i nvestment policy of the Sub-Fund is to invest 100% of its net assets in a portfolio of equity securities that consists of the equity se curities of the Index. The Investment Manager may d eviate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.
The Sub-Fund attempts to replicate, before fees and expenses, the performance of the Index. The Invest ment Manager will seek to do this by replicating so far as possible the inves tments in the Index by holding all of the securitie s comprising the Index in approximately the same proportion as its weighting in the Index.
The base currency of the Sub-Fund is the United Ara b Emirates Dirham (“AED”). The Net Asset Value per Share will be published and settlement and dealing will be effected in the designated currency of each Class.
The shares of the active Sub-Fund are listed and ad mitted for trading on the following stock exchanges : Class A Accumulating Shares are listed on the Dubai Financial Market while Class D Distributing Shares are listed on Abu Dhabi Securities Exchange.
2. Significant Accounting Policies
(a) Basis of preparation
The ICAV’s annual report and audited financial stat ements have been prepared in accordance with Intern ational Financial
Reporting Standards (“IFRS”) as adopted by the Euro pean Union (“EU”), the ICAV Act, the UCITS Regulati ons and the Central
Bank UCITS Regulations.
Page 24
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 21
2. Significant Accounting Policies (continued)
(a) Basis of preparation (continued)
The financial statements have been prepared on a go ing concern basis which assumes that the ICAV will continue in operational existence for the foreseeable future and have been prepared under the historical cost convention, as m odified by the revaluation of financial assets and financial liabilities at fair value through profit or loss.
In making the going concern assessment, the Directo rs have considered the level of subscriptions and r edemptions during the financial year and the ICAV's ability to meet its p ayments as they fall due and assessed that any addi tional repayments may be met out of operating cash flows or raising further capital.
The preparation of the annual report and audited fi nancial statements in conformity with IFRS requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the reporting date and the reported amounts of revenues and expenses during the reporting period. Although thes e estimates are based on management’s best knowledg e of the amount, event or actions, actual results ultimately may differ from those estimates.
The Directors make estimates and assumptions concer ning the future of the ICAV. The resulting accounti ng estimates will, by definition, seldom equal the related actual results . There are no estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities.
International Financial Reporting Standards
New accounting standards, amendments and interpretat ions in issue and effective for the financial perio ds beginning on or after 1
January 2022
At the date of approval of these annual report and audited financial statements, the following standar ds, amendments and interpretations to existing standards effective for financial periods beginning on or after 1 January 2022 have been adopted by the ICAV.
Onerous Contracts - Cost of Fulfilling a Contract (Amendments to IAS 37)
IAS 37 Provisions Contingent Liabilities and Contin gent Assets did not specify which costs to include in estimating the cost of fulfilling a contract for the purpose of assessing whether that contract is onerous. Research conducte d by the IFRS Interpretations Committee indicated that differing views on which c osts to include could lead to material differences in the financial statements of entities that enter into some types of contracts.
In this project, the IASB developed amendments to I AS 37 to clarify that for the purpose of assessing whether a contract is onerous, the cost of fulfilling the contract includ es both the incremental costs of fulfilling that co ntract and an allocation of other costs that relate directly to fulfilling contracts.
The IASB issued the amendments in May 2020. The ame ndments are effective for contracts for which an en tity has not yet fulfilled all its obligations on or after 1 January 2022 with earlier application permitted.
The adoption of Onerous Contracts - Cost of Fulfill ing a Contract (Amendments to IAS 37) did not have a significant impact on the ICAV’s financial statements.
Annual Improvements to IFRS Standards 2018–2020
There were four proposed amendments included in the annual improvements consultation document and those relevant to the ICAV are:
IFRS 9 Financial Instruments
Clarify the fees a company includes in assessing th e terms of a new or modified financial liability to determine whether to derecognise a financial liability.
The amendments are effective for annual reporting periods beginning on or after 1 January 2022 with earlier application permitted.
The adoption of Annual Improvements to IFRS Standar ds 2018–2020 did not have a significant impact on t he ICAV’s financial statements.
Page 25
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 22
2. Significant Accounting Policies (continued) (a) Basis of preparation (continued)
International Financial Reporting Standards (continued)
New accounting standards, amendments and interpretat ions in issue and effective for the financial perio ds beginning on or after 1
January 2022 (continued)
There are no other standards, amendments to standards or interpretations that are effective for annual periods beginning on or after 1 January 2022 that have a material effect on the ICAV’s financial statements.
Standards, interpretations and amendments to existing standards in issue but not yet effective and not early adopted
At the date of approval of these annual report and audited financial statements, the ICAV has not appl ied the following new and revised IFRS Standards that have been issued but are not yet effective:
New and revised IFRSEffective for annualperiods beginningon or after
Amendments to IAS 1 Classification of Liabilities as Current or Non-Current 1 January 2023
Amendments to IAS 1 and IFRS Practice Statement 2 Disclosure of Accounting Policies 1 January 2023
Amendments to IAS 8 Definition of Accounting Estimates 1 January 2023
Amendments to IAS 12 Deferred Tax related to Assets and Liabilities arising from a Single
Transaction 1 January 2023
The ICAV is currently evaluating the impact, if any, that these amendments will have on its financial statements.
There are no other standards, interpretations and a mendments to existing standards in issue but not ye t effective that would be expected to have a significant impact on the ICAV.
(b) Financial assets and financial liabilities at fair value through profit or loss
(i) Classification
The ICAV classifies its investment portfolio based on its business model for managing those financial assets and the contractual cash flow characteristics of the financial assets. The portfolio of financial assets is managed and pe rformance is evaluated on a fair value basis. The ICAV is primarily focused on fair value information and uses that information to asse ss the assets’ performance and to make decisions. The ICAV has not taken the o ption to irrevocably designate any equity securitie s as fair value through other comprehensive income. As such, the ICAV class ifies its entire investment portfolio consisting of equities as financial assets at fair value through profit or loss.
Financial assets that are not classified at fair va lue through profit or loss include cash and cash eq uivalents and receivables.
Financial liabilities that are not at fair value th rough profit or loss include bank overdraft (if any ) and payables. These other financial assets and financial liabilities are held at amortised cost.
(ii) Recognition, derecognition and measurement
Purchases and sales of investments are recognised o n trade date basis, the date on which the ICAV comm its to purchase or sell the asset. Financial assets and financial liabilities a t fair value through profit or loss are initially r ecognised at fair value. Transaction costs are expensed as incurred in the Statement of Comprehensive Income.
Investments are derecognised when the rights to receive cash flows from the investments have expired o r the ICAV has transferred substantially all risks and rewards of ownership and a realised gain or loss is recognised. Realised g ains and losses are presented in the Statement of Comprehensive Income under “net ga in/(loss) on financial assets at fair value through profit or loss”.
Subsequent to initial recognition, all financial as sets and financial liabilities at fair value throug h profit or loss are measured at fair value. Gains and losses arising from changes in the fair value of the financial assets or financial li abilities at fair value through profit or loss are presented in the Statement of Co mprehensive Income within “net gain/(loss) on finan cial assets at fair value through profit or loss”.
Page 26
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 23
2. Significant Accounting Policies (continued)
(b) Financial assets and financial liabilities at fair value through profit or loss (continued)
(iii) Fair value estimation
Equity instruments listed, traded or dealt on a reg ulated market for which market quotations are readi ly available shall be valued at the last traded price at the valuation point in the relevant regulated market on the relevant dealing day, provided that the value of the investment listed, traded or dealt in on a regu lated market but acquired or traded at a premium or at a discount outside or off the relevant stock exchange may be valued, taking i nto account the level of premium or discount as at the date of valuation of the investment and The Bank of New York Mellon SA/NV, D ublin Branch (the “Depositary”) must ensure that th e adoption of such procedure is justifiable in the context of establishing the probable realisation value of the security.
If prices for an investment listed, traded or dealt in on the relevant regulated market are not availa ble at the relevant time or are unrepresentative, or in the event that any investme nts are not listed or traded on any regulated marke t, such investment shall be valued at such value as shall be certified with car e and good faith as the probable realisation value of the investment by a competent professional person appointed by the Dire ctors and approved for such purpose by the Deposita ry which may be the Investment Manager.
In the event of it being impossible or incorrect to carry out a valuation of a specific investment in accordance with the valuation rules set out above or if such valuation is not rep resentative of an asset's fair market value, a comp etent person appointed by the ICAV and approved for the purpose by the Depositary is entitled to use such other generally recognised valuation method in order to reach a proper valuation of that specific instru ment, provided that such method of valuation has be en approved by the Depositary and the method used shall be clearly documented.
No instruments have been valued in this manner as at 31 December 2022 and 31 December 2021.
Impairment
The ICAV recognises loss allowances of expected cre dit loss (“ECL”) on financial assets measured at am ortised cost. When determining whether the credit risk of a financial asset has increased significantly since initial rec ognition and when estimating ECLs, the ICAV considers reasonable and supportable information that is relevant and available without undue cost or effort. This includes both quantitative and qualitative informat ion and analysis, based on the ICAV's historical ex perience and informed credit assessment and including forward–looking informatio n.
ECLs are a probability–weighted estimate of credit losses. Credit losses are measured as the present v alue of all cash shortfalls (i.e. the difference between the cash flows due to the entity in accordance with the contract and the cash flows that the ICAV expects to receive). ECLs are discounted at the eff ective interest rate of the financial asset. The am ount of expected credit losses is immaterial for financial assets.
(c) Foreign currency translation
(i) Functional and presentation currency
The functional and presentation currency of the Sub -Fund is the AED which is the currency of the prima ry economic environment in which it operates. The functional currency of th e Sub-Fund has been evaluated by the Directors base d on the currency that most faithfully represents the economic effects of the u nderlying transactions, events, investors’ base and conditions. The presentation currency of the ICAV is also the AED.
(ii) Transactions and balances
Monetary assets and liabilities denominated in curr encies other than the functional currency are trans lated into the functional currency at the closing rate of exchange at the yea r end date. Foreign currency transactions are trans lated into the functional currency using the exchange rates prevailing at the dates of the transactions. Foreign exchange gains and losses resulting from the settlement of such transactions and from the transl ation at year end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the Statement of Comprehensive Income.
Page 27
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 24
2. Significant Accounting Policies (continued) (c) Foreign currency translation (continued)
(ii) Transactions and balances (continued)
All other foreign currency exchange differences rel ating to monetary items, including cash are present ed in the Statement of Comprehensive Income.
Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value are translated at the foreign currency exchange rates ruling at the dates that the values were determined.
(d) Transaction costs
Transaction costs are incurred on the acquisition o r disposal of financial assets or financial liabili ties at fair value through profit or loss. They include fees and commissions paid to age nts, advisors, brokers and dealers, interest or tax es payable in respect of purchase and sale transactions. Transaction costs when incurred are expensed immediately and are included within net gain/loss on financial assets and financial liabilities at fair value through profit and loss in the Statement of C omprehensive Income. Please refer to Note 9 for more details.
(e) Dividend income
Dividends are credited to the Statement of Comprehe nsive Income on the dates on which the relevant sec urities are listed as “ex dividend”.
(f) Interest income and interest expense
Bank interest income and expenses are recognised in the Statement of Comprehensive Income on an effective yield basis.
(g) Redeemable participating shares
Redeemable participating shares are redeemable at t he shareholder’s option and are classified as finan cial liabilities in accordance with IAS 32. Any distributions on these shares are recognised in the Statement of Changes in Net Asset s Attributable to Holders of Redeemable Participating Shares.
The Primary Market is the market on which shares of the Sub-Funds are issued by the ICAV to Authorised Participants or redeemed by the ICAV from Authorised Participants. Only Authorised Participants are able to subscribe or redeem shares on the Primary Market.
Subscriptions
Subscription of shares may be settled in cash, in-kind or in a combination of both, at the Manager’s d iscretion.
In-kind subscriptions
A Shareholder may subscribe for shares in-kind in a unit of the minimum subscription amount as set out in the relevant Supplement, or a multiple thereof, in return for a basket of component securities (“Component Securiti es”) and a cash component.
The Component Securities shall comprise some or all of the assets which may be invested in by the rele vant Sub-Fund in accordance with the investment objective and policy of that Sub-Fund and the Depositary must be satisf ied that there is unlikely to be any material prejudice to the existing Shareholders through the acceptance of the in-kind subscription.
Cash subscriptions
While subscriptions will normally only be accepted in-kind, the ICAV may on an exceptional basis accep t subscription for shares in cash.
Page 28
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 25
2. Significant Accounting Policies (continued) (g) Redeemable participating shares (continued) Redemptions
The ICAV may pay redemptions either in kind or in cash.
In-kind redemptions
A Shareholder may effect an in-kind redemption of t heir shares through an interdependent redemption pr ocess whereby (1) the ICAV shall agree to redeem a set number of shares i n the ICAV; and (2) the Shareholder shall agree to purchase the underlying Component Securities at an agreed price.
Cash redemptions
While redemptions will normally only be in-kind, th e ICAV may on an exceptional basis accept a request from a Shareholder to redeem Shares in cash.
Subscriptions and Redemptions (Secondary Market)
Shares may be purchased or sold on the Secondary Ma rket by all investors through a relevant stock exch ange on which the shares are admitted to trading or over the counter.
Shares of a Sub-Fund purchased on the Secondary Mar ket cannot usually be sold directly back to the ICA V. Investors must buy and sell shares on a Secondary Market with the assi stance of an intermediary (e.g. a broker) and may i ncur fees for doing so. In addition, investors may pay more than the current N et Asset Value when buying shares and may receive l ess than the current Net Asset Value when buying shares and may receive less than the current Net Asset Value when selling them.
(h) Expenses
Expenses are recognised in the Statement of Compreh ensive Income on an accruals basis. Only management fees are charged to the Statement of Comprehensive Income and the Manag er is responsible for discharging from the manageme nt fee, the other operational fees and expenses of the ICAV including Directors' fees but excluding establishment expens es which are borne by the Investment Manager.
(i) Gains/(losses) on financial assets and liabilities at fair value through profit or loss
All realised and unrealised gains and losses on sec urities are recognised as net gain/(loss) on financ ial assets and financial liabilities at fair value through profit or loss in the Statement of Comprehensive Income. The cost of securities sold is accounted for on an average cost basis.
Unrealised gains and losses consist of movement in the fair value of financial instruments between the opening and closing financial year. Realised gains and losses represent the difference between an instrument’s initial car rying amount and disposal amount, or cash payments.
(j) Cash flows
The ICAV has prepared a Statement of Cash Flows usi ng the direct method, whereby major classes of cash receipts and payments related to operating activities are disclosed.
(k) Dividend policy
The Sub-Fund offers Classes of shares that accumula te income or pay regular dividends out of net incom e and realised and unrealised gains net of realised and unrealised los ses attributable to the relevant share class. The d istribution of dividends is not guaranteed and is subject to the sole discretion of the Directors.
Accumulating Classes
The Directors currently do not intend to declare or pay dividends with respect to the accumulating classes of shares. Therefore, any net income and realised and unrealised gains net of realised and unrealised losses attributable to the shares of the accumulating classes of shares will be accumulated and reflected in their respective Net Asset Values per Share.
Page 29
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 26
2. Significant Accounting Policies (continued)
(k) Dividend policy (continued)
Distributing Classes
For the distributing classes of shares, the Directo rs may declare and pay dividends to the relevant Sh areholders semi-annually on the distribution date. As the Index seeks to track the price performance of the companies contained wi thin the Index and distributions made by those companies, dividends in respect of the distributing classes of shares will be calculated by reference to the embedded reinvested dividends within the Index during the relevant dividend period less taxes, inc luding withholding taxes.
As such, there is no guarantee that any dividend wi ll be paid in respect of the distributing classes. Dividends will be calculated so that any dividend declared will never be more than the excess performance of the total return performa nce of the Sub-Fund. The total return performance of the Sub-Fund is calcula ted by reference to the price return performance of the Index over the relevant calculation period (i.e. the relevant dividend period).
Such dividends shall be paid out of net income and realised and unrealised gains net of realised and u nrealised losses attributable to the relevant share class of the Sub-Fund.
(l) Withholding tax
Dividend and interest income received by the ICAV m ay be subject to withholding tax imposed in the cou ntry of origin, which is shown separately in the Statement of Comprehensive Income.
(m) Cash and cash equivalents and bank overdrafts
Cash comprises of cash on hand and demand deposits. Cash equivalents, if any, are short term, highly l iquid investments with original maturities of three months or less that ar e readily convertible to known amounts of cash and which are subject to insignificant changes in value. Bank overdrafts are short term financing options which are repayable o n demand. There were no bank overdraft balances at 31 December 2022 and 31 December 2021.
(n) Offsetting
Financial assets and financial liabilities are offs et and the net amount reported in the Statement of Financial Position when there is a legally enforceable right to offset the recognise d amounts and there is an intention to settle on a net basis or realise the asset and settle the liability simultaneously. As at 31 Decem ber 2022 and 31 December 2021, no financial assets and financial liabilities were offset in the Statement of Financial Position.
Income and expenses are presented on a net basis on ly when permitted under IFRS, for example, gains an d losses from financial instruments at fair value through profit or loss and foreign exchange gains and losses.
(o) Establishment expenses
The cost of establishing the ICAV and its initial S ub-Fund and obtaining authorisation/approval from t he Central Bank of Ireland were borne by the Investment Manager.
3. Financial Risk Management
(a) Investment strategy
Chimera Capital Limited acts as the Investment Mana ger to the Sub-Fund pursuant to the Management Agre ement.
The detailed
investment objectives and policies of the Sub-Fund are set out in the Prospectus.
In order to achieve its investment objective, the i nvestment policy of the Fund is to invest 100% of i ts net assets in a portfolio of equity securities that consists of the equity secur ities of the Index. The Investment Manager may devi ate from the 100% investment where it is, for whatever reason, not possible to buy and hold a particular Index security.
The Fund attempts to replicate, before fees and exp enses, the performance of the Index. The Investment Manager will seek to do this by replicating so far as possible the investme nts in the Index by holding all of the securities c omprising the Index in approximately the same proportion as its weighting in the Index. The Investment Manager will monitor t he Fund's tracking accuracy on a daily basis and will seek to maintain an appropriate correlation between the return of t he Index and the return of the Fund. It is expected, but not guaranteed that the l evel of tracking error will be 0-2% in normal marke t conditions excluding Management Fees.
Page 30
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 27
3. Financial Risk Management (continued)
(a) Investment strategy (continued)
There can be no assurance that each Fund will achie ve its investment objective. The value of shares an d the income therefrom may rise or fall as the capital value of the equity sec urities in which a Fund invests may fluctuate. The investment income of a Fund is based on the income earned on the equity securities it holds, less expenses incurred. Therefore, a Fun d's investment income may be expected to fluctuate in response to changes in such income or expenses.
The Fund attempts to replicate, before fees and expenses, the performance of the Index.
In pursuing its investment objective, the ICAV is e xposed to a variety of risks: pricing and valuation risk, counterparty and settlement risk, foreign currency risk, credit risk , liquidity risk and other risks that could result in a reduction in the ICAV’s net assets. Risk information is outlined in the Prospectus.
The nature and extent of the financial instruments held at the reporting date and the risk management policies employed by the ICAV are discussed below.
(b) Market Price Risk
Market price risk is the risk that the fair value o r future cash flows of a financial instrument will fluctuate because of changes in market prices. The Sub-Fund is susceptible to marke t price risk arising from uncertainties about futur e prices of the instruments.
The maximum risk resulting from financial instruments is determined by the fair value of the financial instruments.
Sensitivity Analysis
The tables below summarise the sensitivity of the S ub-Fund’s net assets attributable to holders of red eemable participating shares to market price movements. It shows the increase/(d ecrease) in the net assets attributable to holders of redeemable participating shares for the Sub-Fund’s given a 5% movement in th e underlying investment prices at year-end; all oth er variables remaining constant (5% is considered to be a reasonable possible change in price):
31 December 2022
Sub-Fund Currency 31 December 2022Chimera S&P UAE UCITS ETF AED 6,541,386
31 December 2021
Sub-Fund Currency 31 December 2021Chimera S&P UAE UCITS ETF* AED 9,615,250
*Chimera S&P UAE UCITS ETF launched on 23 February 2021.
(c) Counterparty Credit & Settlement Risk
All security investments are transacted through bro kers who have been approved by the Management Compa ny as an acceptable counterparty. The list of approved brokers is revie wed regularly. There is a risk of loss if a counter party fails to perform its financial or other obligations to the Sub-Fund, for example, the possibility that a counterparty may d efault, by failing to make payments due, or make payments in a timely manner. If settlement never occurs the loss incurred by the Sub-Fund will be the difference between the price of the original contra ct and the price of the replacement contract or, in the case where the contract is not replaced the absolute value of the contract at the time it is voided. Further, in some markets ‘De livery versus Payment’ may not be possible in which case the absolute value of the contract is at risk if the Sub-Fund meets its settlement obligations but the counterparty fails before meeting its obligations.
As at 31 December 2022 and 31 December 2021, the Sub-Fund did not hold any forward exchange contracts.
(d) Foreign Currency Risk
Currency risk is the risk that the value of the Sub-Fund’s net assets will fluctuate due to changes in foreign currency rates.
Page 31
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 28
3. Financial Risk Management (continued)
(d) Foreign Currency Risk (continued)
The Sub-Fund can hold assets denominated in currenc ies other than AED, the functional currency. It can therefore be exposed to currency risk, as the value of the securities denom inated in other currencies will fluctuate due to ch anges in the exchange rates. As at 31 December 2022 and 31 December 2021, the Sub-F und did not hold assets denominated in currencies o r then AED, the functional currency. Therefore, the Sub-Fund was no t materially exposed to currency risk at 31 Decembe r 2022 and 31 December 2021.
(e) Credit Risk
Credit risk is the risk that a counterparty or issuer will be unable to meet a commitment it has entered into with the Sub-Fund.
The Bank of New York Mellon SA/NV, Dublin Branch (t he “Depositary”) has been appointed as Depositary t o the ICAV.
Depending on the requirements of the jurisdictions in which the investments of the Sub-Fund are issued , the Depositary may use the services of one or more sub-custodians. Bankrup tcy or insolvency of the Depositary may cause the S ub-Fund’s rights with respect to securities held to be delayed or limited . The Depositary is a branch of The Bank of New Yor k Mellon SA/NV. The Depositary held an AA- long term credit rating from the rating agency Standard and Poor’s as at 31 Dec ember 2022 (31 December 2021: AA-). The Depositary is responsible for the safe-keeping of the assets of the Sub-Fund.
The Depositary may, however, appoint any person or persons to be the sub-custodian of such assets but any liability of the Depositary shall not be affected by the fact that it has entrusted some or all of the assets in its safekeeping to any third party.
The Manager considers that the risk that counterpar ties would fail to discharge their obligations to t he Sub-Fund is low. Any credit risk issues will be discussed quarterly with the Directors and monitored thereafter.
The Sub-Fund holds a proportion of its assets in ca sh. All securities transactions are cleared through and held in custody by the Depositary. The Sub-Fund is subject to the credit r isk to the extent that this institution may be unab le to fulfil its obligation either to return the Subs-Funds securities or repay amount s owed. For these financial instruments, the maximu m credit risk amount at 31
December 2022 is represented by the amount at which they are included in the Statement of Financial Po sition. In the event of insolvency or bankruptcy of the Depositary or Broke r, the Sub-Fund will be treated as a general credit or in relation to cash held with the relevant Depositary or Broker.
As at 31 December 2022 and the financial period end ed 31 December 2021, the Sub-Fund’s financial asset s exposed to credit risk amounted to the following:
Chimera S&P UAEUCITS ETFAs at 31 December2022AEDTransferable securities 130,827,727Cash and cash equivalents 3,091,743Total 133,919,470
Chimera S&P UAEUCITS ETF*As at 31 December2021AEDTransferable securities 192,305,007Cash and cash equivalents 469,871Other assets 79,301Total 192,854,179
*Chimera S&P UAE UCITS ETF launched on 23 February 2021.
Page 32
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 29
3. Financial Risk Management (continued)
(f) Interest Rate Risk
This is the risk that the fair value of future cash flows of a financial instrument will fluctuate bec ause of changes in market interest rates. The majority of the Sub-Fund's financial ass ets are equity shares and other instruments which n either pay interest nor have a maturity date. Cash balances of the Sub-Fund are not subject to significant interest rate risk.
(g) Liquidity Risk
In normal market conditions the assets of each Sub- Fund comprise mainly realisable investments which c an be readily sold. A Sub-Fund’s main liability is the redemption of any shares that investors wish to sell. In general, the investments, including cash, of each Sub-Fund are managed so that it can meet its l iabilities. Investments held may need to be sold if insufficient cash is available to finance such redemptions. If the size of the dis posals are sufficiently large, or the market is ill iquid, then there is a risk that either the investments might not be sold or the pri ce at which they are sold may adversely affect the Net Asset Value of the Sub- Fund. The ICAV employs an appropriate liquidity ris k management process, which takes into account effi cient portfolio management transactions employed by the Sub-Fund, i n order to ensure that each Sub-Fund is able to com ply with its stated redemption obligations. However, it is possible tha t in the type of circumstances described above, a S ub-Fund may not be able to realise sufficient assets to meet all redemption re quests that it receives or the ICAV may determine t hat the circumstances are such that meeting some or all of such requests is not in the best interests of the Shareholders in a Sub-Fu nd as a whole. In such circumstances, the settlement of redemption proceed s may be delayed and / or the ICAV may take the dec ision to apply the redemption gate provisions described under “Procedu re for Dealing on the Primary Market” in the “Purch ase and Sale Information” section or suspend dealings in the rel evant Sub-Fund as described under “Temporary Suspen sion of Dealings” in the “Determination of Net Asset Value” section of the P rospectus.
The following table analyses the ICAV’s financial l iabilities into relevant maturity groupings based o n the remaining year at the financial year ended 31 December 2022 and the financial period ended 31 December 2021 to the contractual maturity date.
Chimera S&P UAE UCITS ETFAs at 31 December 2022 Less than1 month Total
AEDAED
Accrued Management fees342,448342,448
Distributions Payable2,143,1002,143,100
Net assets attributable to holders of redeemable participating shares131,433,922131,433,922
133,919,470133,919,470
Chimera S&P UAE UCITS ETF*
As at 31 December 2021 Less than 1 month Total
AEDAED
Accrued Management fees329,566329,566
Net assets attributable to holders of redeemable participating shares192,524,613192,524,613
192,854,179192,854,179
*Chimera S&P UAE UCITS ETF launched on 23 February 2021.
Page 33
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 30
3. Financial Risk Management (continued)
(h) Global Exposure
Global Exposure refers to the measure of a Sub-Fund 's risk exposure that factors in the market risk ex posure of underlying investments, inclusive of the implied leverage asso ciated with FDIs held in the portfolio. Under the U CITS Regulations, a Sub- Fund is required to use either a “Commitment Approa ch” or a “Value-at-Risk (VaR) Approach” to measure their Global Exposure.
VaR is a statistical methodology that predicts, usi ng historical data, the maximum potential daily los s of a Sub-Fund that can arise at a given confidence level over a specific time pe riod under normal market conditions. VaR may be exp ressed in absolute terms as a percentage of the Sub-Fund assets or in relati ve terms, where the VaR of the Sub-Fund is divided by the VaR of its relevant benchmark, generating a ratio known as relative VaR . The Commitment Approach represents a methodology to measure global exposure based on the calculation of the portfolio leverage which includes the netting and hedging of FDI that the Sub-Fund may have in place according to the UCITS Regulations. A Sub-Fund, which is using the Commitment Approach t o measure its Global Exposure, is limited to 100% commitment leverage.
The Sub-Fund employs the Commitment Approach. The F und’s global exposure (as prescribed in the Central Bank UCITS Regulations) relating to FDI’s shall not exceed 100 % of the NAV of the Fund and will be measured using the Commitment Approach. The Commitment Approach methodology aggre gates the underlying market or notional values of F DIs to determine the degree of global exposure of a Sub-Fund to FDIs.
The Manager has a risk management process in respec t of the Sub-Fund which enables it to accurately me asure, monitor and manage the various risks associated with FDI, the u se of efficient portfolio management techniques and the management of collateral. The Investment Manager will only employ FDI that are covered by the risk management proces s, as amended from time to time. A statement of this risk management process has been submitted to and cleared by the Central Bank.
In the event of a Fund proposing to use additional types of FDI, the risk management process and the S upplement will be amended to reflect this intention and the Fund will not uti lise such FDI until such time as the risk managemen t process providing for its use has been submitted to and cleared by the Central Ba nk. The Manager will, on request, provide supplementary information to shareholders relating to the risk management method s employed including the quantitative limits that a re applied and any recent developments in the risk and yield characteristics of the main categories of investment.
(i) Fair Value
IFRS 13 ‘Fair Value Measurement' requires disclosur e relating to the fair value hierarchy in which fai r value measurements are categorised as assets and liabilities in the Statement of Financial Position.
The disclosures are based on a three-level fair val ue hierarchy for the inputs used in valuation techn iques to measure fair value.
The fair value of financial assets and financial li abilities traded in an active market (such as tradi ng securities) are based on quoted market prices at the close of trading on the reporting date.
A financial instrument is regarded as quoted in an active market if the quoted prices are readily and regularly available from an exchange, dealer, broker, industry group, pricing s ervice, or regulatory agency, and those prices repr esent actual and regularly occurring market transactions on an arm's length basis. These instruments are included within Level 1 of the hierarchy.
The fair value of financial assets and financial li abilities that are not traded in an active market i s determined by using valuation techniques. The ICAV uses a variety of methods and makes assumptions that are based on market conditio ns existing at the reporting date. These instruments are included within Level 2 of the hierarchy. The fair value hierarchy has the following levels:
• Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).
• Inputs other than quoted prices included within Lev el 1 that are observable for the asset or liability , either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).
• Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).
Transfers are deemed to occur at the end of the financial year.
There were no transfers between levels during the financial year ended 31 December 2022 and the financial period ended 31
December 2021 for the Sub-Fund.
Page 34
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 31
3. Financial Risk Management (continued)
(i) Fair Value (continued)
The following tables provide an analysis of financi al instruments at 31 December 2022 and 31 December 2021 that are measured at fair value in accordance with IFRS 13:
Chimera S&P UAE UCITS ETF
Financial Assets at Fair Value through Profit or Loss
As at 31 December 2022
Level 1 Level 2 Level 3 Total
AEDAEDAEDAED
Transferable securitiesEquities 130,827,727
––130,827,727
Total130,827,727––130,827,727
Chimera S&P UAE UCITS ETF *
Financial Assets at Fair Value through Profit or Loss
As at 31 December 2021
Level 1 Level 2 Level 3 Total
AEDAEDAEDAED
Transferable securitiesEquities 192,305,007
––192,305,007
Total192,305,007––192,305,007
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
Assets and liabilities not carried at fair value but for which fair value is disclosed
The ICAV’s assets and liabilities (by class) not me asured at fair value at 31 December 2022 and 31 Dec ember 2021 but for which fair value is disclosed within the fair value hiera rchy are considered Level 2, except for cash and ca sh equivalents, which are considered Level 1.
Cash and cash equivalents include cash on hand and demand deposits held with banks and brokers.
4. Share Capital
The issued share capital of the ICAV shall be not l ess than the currency equivalent of €2 represented by two subscriber shares of no par value and the maximum issued share capital o f the ICAV shall not be more than 500 billion share s of no par value. The share capital of the ICAV shall at all times equal the Net Asset Value of the ICAV .
The subscriber shares entitle the holders to attend and vote at all meetings of the ICAV but do not en title the holders to participate in the dividends or net assets of any Sub-Fund or o f the ICAV. The holders of the subscriber shares sh all have one vote for each subscriber share held.
Each of the redeemable shares entitles the Sharehol der to participate equally on a pro rata basis in t he dividends and net assets of a Sub-Fund attributable to the relevant Class in resp ect of which they are issued, save in the case of d ividends declared prior to becoming a Shareholder.
Page 35
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued)32
4. Share Capital (continued)
The Directors reserve the right to predesignate any class of shares from time to time, provided that S hareholders in that class shall first have been notified by the ICAV thirty calenda r days in advance that the shares will be predesign ated and shall have been given the opportunity to have their shares redeemed by the ICAV, except that this requirement shall no t apply where the Directors predesignate shares in issue in order to facilitate the creation of an additional class of shares.
Each of the redeemable shares entitles the holder t o attend and vote at meetings of the ICAV and of th e relevant Sub-Fund represented by those shares. No class of shares con fers on the holder thereof any preferential or pre- emptive rights or any rights to participate in the profits and dividends of any oth er class of shares or any voting rights in relation to matters relating solely to any other class of shares.
Any resolution to alter the class rights of the sha res requires the approval of three quarters of the holders of the shares represented or present and voting at a general meeting duly convened in accordance with the Instrument of Incorporation.
The following table shows the share class movement during the financial year ended 31 December 2022 an d the financial period ended 31 December 2021:
Chimera S&P UAE UCITS ETF*
Financial yearended31 December 2022Financial period from1 July 2020 to31 December 2021
Class A Accumulating Shares
Balance at beginning of year/period500,000–
Shares issued**–500,000
Balance at end of year/period500,000500,000
Class D Distributing Shares
Balance at beginning of year/period39,500,000–
Shares issued**3,500,00039,500,000
Shares redeemed**(14,000,000)–
Balance at end of year/period29,000,00039,500,000
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
** Includes in-kind share transactions of Nil share s (31 December 2021: 500,000 shares) valued at AED Nil (31 December 2021:
AED 1,835,000) for Class A Accumulating Shares and 3,500,000 shares (31 December 2021: 39,500,000 shar es) valued at AED 17,193,500 (31 December 2021: AED 172,010,500) for Class D Distributing Shares and in-kind redemptions of 14,000,000 shares (31 December 2021: Nil) valued at AED 72,301,000 (31 December 2021: Nil) for Class D Distributing Shares.
5. Net (Losses)/Gains on Financial Assets at Fair Value Through Profit or Loss
Chimera S&P UAE UCITS ETF*
Financial yearended31 December 2022Financial period from1 July 2020 to31 December 2021
AEDAED
Net realised gains on sale of financial assets at FVTPL15,143,2282,095,645
Net change in unrealised (depreciation)/appreciation on
financial assets at FVTPL(21,674,063)18,650,009
Net (losses)/gains on financial assets at fair value through
profit or loss(6,530,835)20,745,654
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
Page 36
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 33
6. Cash and Cash Equivalents
Cash and cash equivalents held at the financial yea r ended 31 December 2022 and 31 December 2021 are h eld with, The Bank of New York Mellon SA/NV, Dublin Branch (the “Deposita ry”).
The Standard & Poor’s long term credit rating of th e Depositary was AA- at 31 December 2022 (31 December 2021: AA-).
7. Taxation
Under current law and practice, the ICAV qualifies as an investment undertaking as defined in Section 739B of the Taxes Consolidation Act, 1997, as amended. On that basis, it is not chargeable to Irish tax on its income or gains.
However, Irish tax may arise on the happening of a “chargeable event”. A chargeable event includes any distribution payments to Shareholders, any encashment, redemption, cancellation or transfer of Shares and the holding of Shares at the end of each eight year period beginning with the acquisition of such Shares.
No Irish tax will arise on the Sub-Fund in respect of chargeable events in respect of:
(a) transactions by a Shareholder who is neither Ir ish resident nor ordinarily resident in Ireland for tax purposes at the time of the chargeable event, provided the appropriate valid de clarations, in accordance with the provisions of th e Taxes Consolidation Act, 1997, as amended, are held by the Sub-Fund or the S ub-Fund has been authorised by the Irish Revenue to make gross payments in the absence of appropriate declarations; and
(b) transactions by certain exempted Irish resident Shareholders who have provided the Sub-Fund with t he necessary signed statutory declarations.
Dividends, interest and capital gains, (if any), re ceived on investments made by the Sub-Fund may be s ubject to taxes imposed by the country from which the investment income/gains are received, and such taxes may not be recoverable by the Sub-Fund or its Shareholders.
8. Expenses
The ICAV shall pay to the Manager out of the Sub-Fu nd’s assets an annual Management Fee of 1% of the S ub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of manage ment services and such other services as have been agreed with the Manager, incl uding the provision of company secretarial services , MLRO services and the maintenance of the ICAV’s beneficial ownership regi ster) out of the Management Fee and any reasonable and properly vouched expenses as well as extraordinary expenses outside the ordinary course of business where agreed in adv ance with the ICAV and shall further discharge all fees and expenses related to the Sub-Fund.
The following expenses will be discharged by the Ma nager out of the Management Fee: fees payable to th e Depositary, Administrator, Investment Manager, Global Distribut or and Directors and all operational expenses, incl uding but not limited to, expenses and reasonable out of pocket expenses of t he Depositary, Administrator, Investment Manager, G lobal Distributor and Directors, the costs of maintaining the Sub-Funds a nd any registration of the Funds with any governmen tal or regulatory authority; the costs of registering a Fund in other jurisdicti ons or with any stock exchange, filing fees; prepar ation, printing, and posting of the Prospectus and other prospectuses, sales litera ture and reports to shareholders, regulatory fees o f the CBI and other governmental agencies; insurance premiums; fees and expenses for legal, audit, other professionals and other services; levies incurred in connection with acquiring or disposing of Investments or in connection with creation and r edemption transactions including any fees and expenses payable as a result of entering into FDI transactions or arising from investment in collective investment schemes (including, without limitation, any fees, charges, taxes, levies or expenses relate d to the purchase or sale of an amount of any currency, or the patriation or repatr iation of any security or other asset, or related t o the execution of portfolio transactions or any creation or redemption transact ions); fees and expenses incurred in connection wit h securities lending; paying for sublicensing fees related to each Fund's Index and any distribution fees or expenses but excluding interest, taxes, brokerage commissions and other expenses connected with execu tion of portfolio transactions, and extraordinary e xpenses. Where the above expenses exceed the Management Fees, the Investment Manager will discharge any such expenses out of its own assets.
The fees and expenses relating to the establishment and approval of the Sub-Fund, including the fees o f the ICAV’s professional advisers, the fees and expenses incurred with respe ct to registering the shares of the Sub-Fund for sa le in various markets, and the expenses associated with the issue of shares, inclu ding the costs incurred in connection with the prep aration and publication of the Supplement, and all legal and printing costs will be borne by the Investment Manager.
Page 37
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued)34
9. Transaction Costs
Transaction costs are incremental costs that are di rectly attributable to the acquisition, issue or di sposal of a financial asset or financial liability. An incremental cost is one tha t would not have been incurred if the entity had no t acquired, issued or disposed of the financial instrument. When a financial asset or financial liability is recognised initially, an entity shall measure it at its fair value through profit or loss plus, transaction cost s that are directly attributable to the acquisition or issue of the financial asset or financial liability.
Transaction costs on purchases and sales of equitie s are borne by the Sub-Fund and included within net gains/(losses) on investments in the Statement of Comprehensive Incom e. Purchases and sales transaction costs include id entifiable brokerage charges, commissions, transaction related taxes and other market charges.
Transactions costs incurred on purchases and sales during the financial year ended 31 December 2022 am ounted to AED 90,370 (31 December 2021: AED 27,674).
10. Related Parties transactions
According to IAS 24 Related Parties, parties are co nsidered to be related if one party has the ability to control the other party or exercise significant influence over the other party in making financial or operational decisions or is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. The following rel ated party relationships and transactions have been identified. The Directors, M anager and the Investment Manager are considered as key management personnel for this purpose.
The Manager is entitled to receive out of the Sub-F und’s assets an annual Management Fee of 1% of the Sub-Fund’s daily Net Asset Value. The Manager will retain a fee for its remuneration (in respect of the provision of manage ment services and such other services as have been agreed with the Manager, incl uding the provision of company secretarial services , MLRO services and the maintenance of the ICAV’s beneficial ownership regi ster). The Manager is also entitled to be reimburse d for any reasonable and properly vouched expenses (the “Manager’s Expenses” ) as well as extraordinary expenses outside the ord inary course of business where agreed in advance with the ICAV.
Total fees earned by the Manager during the financi al year ended 31 December 2022 amounted to EUR 30,0 00 (31 December 2021: EUR 30,000) of which EUR 2,500 was outstanding at 31 December 2022 (31 December 2021: EUR 2,500).
The emoluments of all the Directors who are entitled to remuneration for their services as Directors in respect of any twelve-month accounting period shall not exceed €80,000 or such higher amount as may be approved by the Board of Di rectors. The Directors are also entitled to be reimbursed for their reason able out of pocket expenses incurred in discharging their duties as Directors.
Such fees and expenses are paid out of the annual management fee paid to the Manager.
Directors’ fees incurred during the financial year ended 31 December 2022 amounted to EUR 40,000 (31 D ecember 2021: EUR 37,500) of which EUR Nil was outstanding at 31 Dece mber 2022 (31 December 2021: EUR Nil). Directors' f ees were earned by 2 of the Independent Directors. None of the Directors who are employees of the Investment Manager or its related entity earned fees during the financial year ended 31 December 2022 and the financial period ended 31 December 2021.
The Investment Manager earned fees for investment m anagement services of AED 1,709,240 during the fina ncial year ended 31
December 2022 (31 December 2021: AED 676,793) of wh ich AED 342,448 was outstanding at 31 December 2022 (31 December 2021: AED 329,566). As with the other expenses, the fees are paid out of the annual management fee paid to the Manager.
At 31 December 2022, the ICAV had four Authorised P articipants, Arqaam Capital, BHM Capital Financial Services PrJSC, EFG Hermes UAE L.L.C and International Securities L.L.C , through which share transactions are conducted on the primary market.
International Securities L.L.C is a related party to the ICAV and the Investment Manager.
At 31 December 2022, the 2 Subscriber shares were held on behalf on the ICAV by the Investment Manager.
11. Contingent Liabilities and Commitments
There were no contingent liabilities or commitments as at the financial year ended 31 December 2022 an d the financial period ended 31 December 2021.
Page 38
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued)35
12. Segregation of Liability
The ICAV is an umbrella fund with segregated liabil ity between Sub-Funds and each Sub-Fund may compris e one or more classes of shares in the ICAV. The Directors may, from time to time, upon the prior approval of the CBI, estab lish further Sub-Funds by the issue of one or more separate classes of shares on such terms as the Directors may resolve. The Di rectors may, from time to time, in accordance with the requirements of the CB I, establish one or more separate classes of shares within each Sub-Fund on such terms as the Directors may resolve.
13. Umbrella Cash Collection Accounts
The CBI published the Central Bank (Supervision and Enforcement) Act 2013 (Section 48(1)) Investor Mon ey Regulations 2015 for Fund Service Providers (the “Investor Money Reg ulations” or “IMR”) in March 2015 (effective from 1 July 2016). The Management Company, together with the Administrator implemented procedures in relation to the way subs cription and redemption monies are channeled to and from the ICA V. These transactions are channeled through an umbr ella cash collection account in the name of the ICAV. Pending issue of t he shares and/or payment of subscription proceeds t o an account in the name of the ICAV or the relevant Sub-Funds, and pending payment of redemption proceeds or distributions, the relevant investor will be an unsecured creditor of the relevant Sub-Fund in r espect of amounts paid by or due to it. As at 31 De cember 2022 and 31
December 2021 , there was no IMR related balance included within ca sh and cash equivalents in the Statement of Financi al Position .
14. Net Asset Value Attributable to Holders of Redeemable Participating Shares
Chimera S&P UAE UCITS ETF*
As at31 December 2022As at31 December 2021
Total Net Asset Value
Class A Accumulating Shares AED 2,359,267 AED 2,478,914 Class D Distributing Shares AED 129,074,655 AED 190,045,699
Net Asset Value per ShareClass A Accumulating Shares AED 4.719 AED 4.958Class D Distributing Shares AED 4.451 AED 4.811
* Chimera S&P UAE UCITS ETF was launched on 23 February 2021.
15. Soft Commissions and Directed Brokerage Arrangements
There were no soft commissions and directed brokera ge arrangements entered into by the ICAV and the Su b-Fund during the financial year ended 31 December 2022 and the financial period ended 31 December 2021.
16. Distributions
Distributions from Chimera S&P UAE UCITS ETF per sh are class during the financial year ended 31 Decemb er 2022 and the financial period ended 31 December 2021 were as follows:
Financial year ended 31 December 2022Share Class Ex Date Pay Date Dividend per Amount
Redeemable ParticipatingShare AEDClass D Distributing Shares 15 June 2022 28 June 2022 0.0586 2,109,600Class D Distributing Shares 15 December 2022 11 January 2023 0.0739 2,143,100Total 4,252,700
Page 39
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 36
16. Distributions (continued)
Financial period ended 31 December 2021 Share Class Ex Date Pay Date Dividend per Amount
RedeemableParticipating Share AED
Class D Distributing Shares 23 June 2021 30 June20210.09601,392,000
Class D Distributing Shares 15 December 2021 10 January20220.03701,332,000
Total 2,724,000
17. Exchange Rates
The following average exchange rate was used to convert certain expense payments to AED:
Financial year ended31 December 2022Financial period ended31 December 2021
EUR0.2588360.231122
18. Efficient Portfolio Management
The Investment Manager may, on behalf of the Sub-Fu nd and subject to the conditions and within the lim its laid down by the Central Bank of Ireland, employ techniques and inst ruments relating to transferable securities and mon ey market instruments for efficient portfolio management purposes in accordance with the investment strategy of the Sub-Fund.
Transactions for the purposes of efficient portfoli o management may be undertaken with a view to achie ving the reduction of risk, the reduction of cost, or the generation of additio nal capital or income for the Sub-Fund with an appr opriate level of risk and taking into account the risk profile of that Fund. Techniques and instruments used for efficient portf olio management purposes may include Investments in financial derivative ins truments (“FDI”) including futures, options and swa ps, the entry into securities lending transactions, repurchase and/or reverse rep urchase agreements. All revenues arising from effic ient portfolio management activities, net of direct and indirect operational costs will be retained by the Sub-Fund and recognis ed in the Statement of Comprehensive Income.
The Sub-Fund did not engage in any efficient portfolio management activities during the financial year ended 31 December 2022.
19. Auditor’s remuneration
The remuneration for all work carried out by the st atutory audit firm, (exclusive of VAT), in respect of the financial year end is as follows:
Financial year ended
31 December 2022EURFinancial period from20 July 2020 to 31 December2021EUR
Statutory audit16,20015,000
16,20015,000
20. Significant Events during the Financial Year
The Coronavirus (“COVID-19”) global pandemic contin ues to impact many aspects of daily life and the global economy.
Effective 3 January 2022, Fridays became a business day in the UAE and as such the ICAV now prepares valuations on Fridays.
The Ukraine Russia war which started on 24 February 2022 has created extensive uncertainty on the poli tical and economic front.
Market analysts are reworking expectations for infl ation and interest rate policy as they assess the e ffects of the conflict. The geopolitical conflict is also challenging the weste rn world, which will likely result in a rethinking of Europe’s dependency on Russian oil and gas. The longer-term impact on econ omies, markets, industries and individual issuers, are not yet known. The ICAV continues to monitor the situation closely.
Effective 14 November 2022, the registered address of the ICAV changed from Suite 5, Block 1 Internati onal Science Centre, National Technology Park, Castletroy, Limerick, Ireland to County Hall, Dooradoyle Road, Limerick, Ireland.
Page 40
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
Notes to the Audited Financial Statements (continued) 37
20. Significant Events during the Financial Year (continued)
Effective, 17 November 2022, Mr. Majed Odeh resigne d as a Director of the ICAV while Mr. Sherif Salem was appointed in his place effective the same day.
Other than the above, there have been no significant events that require disclosure in the financial statements.
21. Subsequent Events after the Financial Year End
Effective 10 March 2023, FundRock Management Compan y S.A. (Ireland Branch) resigned as Secretary to th e ICAV while Bradwell Limited were appointed as Secretary to the ICAV on the same day.
There have been no other significant subsequent eve nts after the financial year end that require discl osure in the financial statements .
22. Valuation Point
As 31 December 2022 falls on a weekend, the valuati on point and prices used for the valuation of inves tments was that of 30
December 2022 being the last business day in the financial year for the relevant market.
23. Whistleblowing Policy
The ICAV has adopted a whistleblowing policy pursua nt to the Protected Disclosures Act 2014, as amende d, which gives legal protection to workers, which includes Directors and Shareholders, who make disclosures, including prot ections against dismissal or being penalised by the ICAV. Further details are available in the policy, which is available on request from the ICAV.
24. Approval of Annual Report and Audited Financial Statements
The annual report and audited financial statements were approved by the Directors on 23 March 2023 .
Page 41
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
38
Schedule of InvestmentsAs at 31 December 2022
Chimera S&P UAE UCITS ETFSecurity Description Nominal Fair Value
AED% ofNet Assets
Transferable securities admitted to an official stock exchange Equities 99.54% (31 December 2021: 99.89%)
United Arab Emirates 99.54% (31 December 2021: 99.89%)
Abu Dhabi Commercial Bank PJSC876,7007,890,3006.00
Abu Dhabi Islamic Bank PJSC457,6694,169,3653.17
Abu Dhabi National Oil Co for Distribution PJSC 905 ,6983,994,1283.04
Abu Dhabi Ports Co PJSC289,2601,660,3521.26
ADNOC Drilling Co PJSC806,4652,403,2661.83
Air Arabia PJSC764,4121,643,4861.25
AL Seer Marine Supplies & Equipment Co LLC63,515598,3110.46
AL Yah Satellite Communications Co-PJSC 326,235 815 ,588 0.62
Aldar Properties PJSC1,139,3865,047,4803.84
Apex Investment Co PSC166,291582,0190.44
Aramex PJSC244,716861,4000.66
Arkan Building Materials Co PJSC297,684473,3180.36
Borouge Plc662,8251,676,9471.28
Dana Gas PJSC1,145,8511,054,1830.80
Deyaar Development PJSC396,753201,1540.15
Dubai Electricity & Water Authority PJSC2,835,2276,577,7275.00
Dubai Financial Market PJSC508,118767,2580.58
Dubai Investments PJSC696,4861,511,3741.14
Dubai Islamic Bank PJSC912,4075,200,7203.96
Emaar Development PJSC280,8021,238,3370.94
Emaar Properties PJSC1,958,38611,476,1428.73
Emirates NBD Bank PJSC776,05610,088,7287.68
Emirates Telecommunications Group Co PJSC1,095,87925,051,79319.06
Fertiglobe plc388,5051,643,3761.25
First Abu Dhabi Bank PJSC1,392,11123,805,09818.12
Ghitha Holding PJSC12,922943,3060.72
Invictus Investment Co Plc38,811148,2580.11
Multiply Group PJSC1,058,4854,911,3703.74
National Marine Dredging Co68,9471,687,8231.29
Q Holding PJSC676,2802,705,1202.06
Total United Arab Emirates130,827,72799.54
Total Equities130,827,72799.54
Total Transferable securities admitted to an official stock exchange130,827,72799.54
Total Financial assets at fair value through profit or loss130,827,72799.54
Cash and cash equivalents3,091,7432.35
Net other liabilities(2,485,548)(1.89)
Total Net assets attributable to holders of redeemable participating
shares131,433,922100.00
Page 42
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
39Schedule of Investments (continued)As at 31 December 2022
Chimera S&P UAE UCITS ETF (continued)
Analysis of total assets% ofTotalAssets
Transferable securities admitted to an official stock exchange listing 97.69
Cash and cash equivalents 2.31Total Assets 100.00
Page 43
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
40
Statement of Portfolio Changes for the financial year ended 31 December 2022 (Unaudited)
Chimera S&P UAE UCITS ETFMajor Purchases*#Security Description Nominal CostAED
Emirates Telecommunications Group Co PJSC952,43332,579,390
Dubai Electricity & Water Authority PJSC3,828,2089,923,287
Emaar Properties PJSC830,7054,810,992
ADNOC Drilling Co PJSC1,202,2304,474,225
First Abu Dhabi Bank PJSC217,6164,360,380
Fertiglobe plc673,7723,602,165
Multiply Group PJSC1,120,9033,482,923
Dubai Islamic Bank PJSC573,2253,434,984
Q Holding PJSC676,2802,895,238
Abu Dhabi Ports Co PJSC432,6422,179,595
Emirates NBD Bank PJSC138,9951,838,658
National Marine Dredging Co68,9471,820,070
Borouge Plc662,8251,710,537
Abu Dhabi Commercial Bank PJSC152,0001,412,122
Ghitha Holding PJSC12,9221,089,609
Aldar Properties PJSC204,5141,016,248
Aramex PJSC244,716968,391
Sharjah Islamic Bank412,057832,574
Apex Investment Co PSC166,291775,119
Abu Dhabi National Oil Co for Distribution PJSC157,058675,731
* In accordance with the Central Bank UCITS Regulat ions, the annual report and audited financial state ments documents material changes that have occurred in the disposition of th e assets of the ICAV during the year. A material ch ange is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or a ggregate disposals greater than 1 per cent of the total value of sales for the year . If there are fewer than 20 purchases/sales that m eet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
# The above table includes Purchases in-kind.
Page 44
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
41
Statement of Portfolio Changes for the financial year ended 31 December 2022 (Unaudited) (continued)
Chimera S&P UAE UCITS ETF
Major Sales*#Security Description Nominal ProceedsAED
First Abu Dhabi Bank PJSC1,729,70036,589,892
Emirates Telecommunications Group Co PJSC998,35628,934,151
Emirates NBD Bank PJSC979,95313,473,927
Abu Dhabi Commercial Bank PJSC1,103,77110,747,841
Emaar Properties PJSC1,492,0538,388,626
Aldar Properties PJSC1,596,3607,501,081
Abu Dhabi Islamic Bank PJSC569,8865,130,788
Dubai Islamic Bank PJSC836,8554,968,768
Abu Dhabi National Oil Co for Distribution PJSC1,134,1464,937,393
Dubai Electricity & Water Authority PJSC992,9812,498,409
Dubai Investments PJSC783,0381,857,236
Air Arabia PJSC859,4091,658,879
Fertiglobe plc285,2671,557,242
Emaar Development PJSC315,6921,413,332
ADNOC Drilling Co PJSC395,7651,390,245
Dana Gas PJSC1,282,1451,370,201
Dubai Financial Market PJSC571,2581,165,302
Al Waha Capital PJSC688,049976,329
AL Yah Satellite Communications Co-PJSC352,843963,228
RAK Ceramics PJSC326,952932,727
* In accordance with the Central Bank UCITS Regulat ions, the annual report and audited financial state ments documents material changes that have occurred in the disposition of th e assets of the ICAV during the year. A material ch ange is defined as aggregate purchases of a security exceeding 1 per cent of the total value of the purchases for the year and/or a ggregate disposals greater than 1 per cent of the total value of sales for the year . If there are fewer than 20 purchases/sales that m eet the material changes definition, the ICAV shall disclose those purchases/sales so at least 20 purchases/sales are disclosed.
# The above table includes Sales in-kind.
Page 45
Chimera UCITS ICAV
Annual Report & Audited Financial Statements For the financial year ended 31 December 2022
42Appendix 1: UCITS V Remuneration Policy (Unaudited)
FundRock Management Company S.A.
FundRock Management Company S.A. (“FundRock”) as su bject to CSSF Circular 18/698 has implemented a rem uneration policy in compliance with Articles 111a and 111b of the 2010 Law and/or Article 12 of the 2013 Law respectively.
FundRock as subject to Chapter 15 of the 2010 Law a nd AIFM must also comply with the guidelines of the European Securities and Markets Authority ESMA/2016/5758 and ESMA/2016/ 5799 to have sound processes in place. has establis hed and applies a remuneration policy in accordance with the ESMA Gui delines on sound remuneration policies under the UC ITS V Directive (ESMA 2016/575) and AIFMD (ESMA 2016/579) and any related legal & regulatory provisions applicable in Luxembourg.
Further, consideration has been given to the requir ements as outlined in Regulation (EU) 2019/2088 on sustainability – related disclosures in the financial sector, the SFDR Requirements.
The remuneration policy is aligned with the busines s strategy, objectives, values and interests of Fun dRock and the Funds that it manages and of the investors in such Funds, and whi ch includes, inter alia, measures to avoid conflict s of interest; and it is consistent with and promotes sound and effective ri sk management and does not encourage risk taking wh ich is inconsistent with the risk profiles, rules or instruments of incorporation of the Funds that the Management Company manages.
FundRock ensures that its remuneration policy adequ ately reflects the predominance of its oversight ac tivity within its core activities. As such, it should be noted that FundRo ck’s employees who are identified as risk-takers ar e not remunerated based on the performance of the funds under management.
A paper version of the remuneration policy is made available free of charge to investors at FundRock’s registered office.
FundRock’s remuneration policy can also be found at :https://www.fundrock.com/policies-and-compliance/remuneration-policy/
The total amount of remuneration for the financial year ending 31 December 2022 paid by FundRock to it s staff: EUR 12,587,217 (31 December 2021: EUR 11,293,609)
Fixed remuneration: EUR 11,485,489 (31 December 2021: EUR 10,565,583)Variable remuneration: EUR 1,101,728 (31 December 2021: EUR 728,026)
Number of beneficiaries: 147 (31 December 2021: 135)
The aggregated amount of remuneration for the finan cial year ending 31 December 2022 paid by FundRock to Identified staff/risk takers is EUR 2,524,731 (31 December 2021: EUR 2,622,285).
The total amount of remuneration is based on a comb ination of the assessment of the performance of the individual, the overall results of FundRock, and when assessing individual performance, financial as well as non-financial criteria are taken into account.
The Policy is subject to annual review by the Compliance Officer and the update is performed by HR department of FundRock and is presented for review to the Remuneration Committee and approval by the Board of FundRock.
Page 46
Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2022
43
Appendix II: Securities Financing Transactions Regulation (“SFTR”) Disclosures (Unaudited)
The ICAV is required to report in the financial sta tements on a semi-annual basis, certain disclosures as set out in Article 13 of the European Commission Regulation 2015/2365 on transpa rency of securities financing transactions and of r euse of collateral (the “Regulation”).
Neither the ICAV nor the Sub-Fund engaged in any se curities financing transactions during the financia l year ended 31 December 2022, as a result, there is nothing to report in that regard.
Page 47
Chimera UCITS ICAVAnnual Report & Audited Financial StatementsFor the financial year ended 31 December 2022
44
Appendix III: Sustainable Finance Disclosure Regulation (“SFDR”) Disclosures (Unaudited)
The investments underlying this financial product d o not take into account the EU criteria for environ mentally sustainable economic activities. This ICAV does not have as its objective sustainable investment, nor does it prom ote environmental or social characteristics. As a result, the ICAV does not fal l within the scope of Regulation (EU) 2020/852 of t he European Parliament and of the Council on the establishment of a framework to facilitate sustainable investment.